Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

BACKGROUND: Surgery is the only treatment option for operable gastric cancer. The CLASSIC and ACTS-GC studies showed that the 5-year overall survival (OS) of patients with stage III gastric cancer undergoing D2 gastrectomy is still very low. Whether adjuvant nanoparticle albumin-bound paclitaxel (na...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xiangdong, Wu, Dan, Xu, Nong, Chen, Luchuan, Yan, Zhilong, Chen, Ping, Zhou, Lei, Yu, Jianfa, Cui, Jiuwei, Li, Wei, Wang, Chang, Feng, Wenming, Wei, Yunhai, Yu, Pengfei, Du, Yian, Ying, Jieer, Xu, Zhiyuan, Yang, Litao, Zhang, Yunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802165/
https://www.ncbi.nlm.nih.gov/pubmed/33435909
http://dx.doi.org/10.1186/s12885-020-07772-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802165/
https://www.ncbi.nlm.nih.gov/pubmed/33435909
http://dx.doi.org/10.1186/s12885-020-07772-7

Ejemplares similares